Compare · head to head
Quest Diagnostics vs Stoke Therapeutics
Quest Diagnostics ranks higher overall — 360 rank 35 vs 16.
Quest Diagnostics leads on Value (42 vs 33), Quality (62 vs 37), Growth (46 vs 36) and Safety (54 vs 43). Stoke Therapeutics leads on Sentiment (62 vs 31).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Health Care |
| Industry | Health Care Providers & Services | Biotechnology |
| Size | X-Large | Small |
| ISIN | US74834L1008 | US86150R1077 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 35 | 16 |
| Value | 42 | 33 |
| Quality | 62 | 37 |
| Growth | 46 | 36 |
| Safety | 54 | 43 |
| Sentiment | 31 | 62 |
| Quality details | ||
| Profitability | 68 | 47 |
| Cash Truth | 56 | 27 |
Quest Diagnostics vs LabcorpQuest Diagnostics vs MistrasQuest Diagnostics vs MasimoQuest Diagnostics vs Adaptive BiotechnologiesAdd a third stock →
Full analyses: Quest Diagnostics · Stoke Therapeutics
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100